This study is looking into whether exposure to rose scent (2-phenylethanol) can help reduce the risk of Sudden Unexpected Death in Epilepsy (SUDEP). SUDEP is a serious concern for people with epilepsy, and researchers want to see if this scent can affect breathing problems during seizures. You might be able to join if you are an adult with epilepsy, at least 18 years old, and admitted to the epilepsy monitoring unit (EMU) at Vanderbilt University Medical Center (VUMC) for observation. The study will measure the number of seizures and breathing episodes you have over 24 hours while exposed to the rose scent. The study is currently unclear about its recruitment status and plans to enroll 40 participants.

Study design

This is an interventional study, meaning participants will receive a specific intervention (rose scent). It is not specified if it is randomized or blinded, and it plans to enroll 40 participants.

What's involved

You would undergo 24 hours of routine monitoring, followed by 24 hours of monitoring with continuous rose scent exposure in your hospital room. You will also wear a respiratory monitoring belt for 48 hours.

Compensation

Not stated in the trial record.

Follow-up

The primary outcomes, such as the number of seizures and breathing episodes, are measured at 24 hours after the rose scent exposure begins.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.